A carregar...
Targeting Akt in cell transfer immunotherapy for cancer
Pharmacologic inhibitors of the serine/threonine kinase Akt, initially aimed at deranged oncogenic pathways in tumors, have recently been shown to act as immunomodulators that markedly enhance the antitumor properties of T cells. Repurposing Akt inhibitors to improve antitumor immunity may be viewed...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5048755/ https://ncbi.nlm.nih.gov/pubmed/27757294 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1014776 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|